Ajovy (fremanezumab) has a half-life of approximately 31 days, meaning it takes about five months to fully clear from your system after your last injection. That long residence time is by design: Ajovy is a monoclonal antibody engineered to stay active in your bloodstream for weeks, which is why you only need to inject it once a month or once every three months.
How the 31-Day Half-Life Works
A drug’s half-life is how long it takes for half of it to leave your body. With a 31-day half-life, roughly half of Ajovy is gone after one month, three-quarters after two months, and so on. It generally takes about five half-lives for a drug to drop to negligible levels. For Ajovy, that works out to approximately 155 days, or just over five months after your final dose.
This is dramatically longer than most medications. A typical over-the-counter pain reliever clears in hours. Ajovy lingers because it’s a large protein molecule, not a small chemical compound. Your body can’t flush it through the liver or kidneys the way it handles most drugs. Instead, your cells gradually break it down into small protein fragments and amino acids through a natural recycling process called enzymatic proteolysis. Because this process bypasses the liver’s usual drug-processing enzymes, kidney or liver function doesn’t meaningfully change how fast Ajovy leaves your system.
Monthly vs. Quarterly Dosing
Ajovy comes in two dosing schedules: 225 mg once a month, or 675 mg (three injections at once) every three months. Both regimens produce similar overall drug exposure over time, but they build up differently.
With monthly dosing, the drug accumulates more between doses. The median accumulation ratio is about 2.3, meaning steady-state levels are roughly 2.3 times higher than what you’d see after a single shot. With quarterly dosing, accumulation is minimal, with a ratio of about 1.2. Regardless of which schedule you’re on, steady-state concentrations take about 5 to 6 months of consistent dosing to reach. After stopping, the clearance timeline is the same for both: around five months from your last injection.
What Affects Clearance Speed
Population studies have looked at whether age, sex, race, kidney function, or use of other migraine medications changes how quickly Ajovy is eliminated. None of these factors significantly altered the drug’s behavior. There were slight trends suggesting women and people with impaired kidney function carried marginally higher drug levels, but the differences were not statistically meaningful and the ranges overlapped across groups.
Ajovy also stays mostly in the bloodstream rather than spreading deeply into other tissues. Its volume of distribution is approximately 6 liters, which is close to the total blood volume of an average adult. This limited distribution means the drug isn’t hiding in fat or muscle tissue, waiting to slowly re-enter circulation. Once blood levels drop, you’re genuinely clearing it.
What Happens After You Stop
If you’ve been on Ajovy for a long stretch, stopping doesn’t produce withdrawal symptoms, but your migraines are likely to return. A real-world study of patients who paused treatment after 24 months of continuous use found that migraine frequency and severity both increased during the pause period, even in people who had been responding well. The drug doesn’t reset your migraine biology permanently; it suppresses attacks while it’s active in your system, and that protection fades as levels drop.
Because the drug clears slowly, you won’t necessarily notice an immediate change. Some people report a gradual return of migraine attacks over the weeks following their last dose rather than a sudden rebound. The timeline varies, but the protective effect generally weakens as blood concentrations fall below therapeutic levels, which starts happening a few weeks after a missed dose.
Side Effects Can Linger Too
The same slow clearance that keeps Ajovy working also means side effects can appear or persist well after injection day. Hypersensitivity reactions, including rash, itching, and hives, have been reported anywhere from hours to a full month after a dose. Most are mild to moderate, though some have required treatment. If you develop a new skin reaction weeks after your last injection, the drug is still a plausible cause.
Planning for Pregnancy
The five-month clearance window is especially relevant if you’re planning to conceive. Because Ajovy is a large antibody that crosses the placenta, particularly in the second and third trimesters, many clinicians recommend stopping well before conception. MotherToBaby, a service of the Organization of Teratology Information Specialists, advises that it may take approximately five months for Ajovy and similar anti-CGRP antibodies to clear. If having the drug fully out of your system before pregnancy matters to you, that five-month window is the number to plan around.